Lotus Bio-Technology Development Corp. announced that it will receive $50,000 in funding on December 14, 2022. The company will issue common shares in the transaction.

The minimum investment accepted from any outside investor is $10,000. The company intends to continue the transaction for more than one year. The company will issue securities pursuant to exemption provided under Regulation D.